| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Teleselling > Why Cold Calling Detractors Don't Belong In Sales Work |
|
Advice You - Why Cold Calling Detractors Don't Belong In Sales Work
I’ve had it up to here with self-appointed sales experts who pop-off with nothing but di According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product srespect for cold-calling. They don’t know what they’re talking about and they appeal t ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in o the worst possible motivation in other salespeople: The desire to get something for no lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. hing. Cold calling takes work, and genuine salespeople don’t mind that one bit. As Vinc here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e Lombardi, the legendary Green Bay Packers coach said, true winners love to not only be d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro on the field of play, but to leave it, exhausted, knowing they did their best. Show me ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc someone who boasts that he “Prefers to work SMART, and not HARD,” and I’ll show you: (1) easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi Either a certified genius who has found or built a perpetual motion machine; or (2) A l nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ar, who not only deceives himself, but others, too. I tell them this: IT IS SMARTER TO and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ WORK HARDER. There’s something else about the anti-cold callers that is disconcerting. ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi hey’re RISK-AVERSE. They want a sure thing, and they know that prospecting for new busin ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ess is anything but certain, especially if you’re too lazy to commit to it. Every sales dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod person risks rejection and investing time that won’t immediately pay off in a sale. But cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ho can totally cherry-pick his prospects as to guarantee he’ll always win and never lose tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ? I’ll tell you who can do this. Passive CLERKS can; the ones who do nothing but answer t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel inbound calls and fulfill orders from a catalogue. They don’t act; they react. And for t ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust he most part, they get a nice, steady, pauper’s paycheck to do that 51 weeks a year with y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products one week off, for good behavior. If you don’t want to work hard and if you fear taking . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de risks and you need a sure thing to feel warm and fuzzy, leave the sales game right now. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip And don’t bash cold callers who are really working, and producing results, for a living tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Hate Your Job? What to Do, What Not to Do Get the Right Partner - Recipe of Offshore Vendor Evaluation
|